Skip to main content
. Author manuscript; available in PMC: 2015 Mar 20.
Published in final edited form as: Addiction. 2012 Oct 29;107(Suppl 1):83–90. doi: 10.1111/j.1360-0443.2012.04042.x

Table 1.

Maternal characteristics of opioid-dependent pregnant women maintained on methadone or buprenorphine

Buprenorphine (n = 58) Methadone (n = 73)
Variable Mean (SD); % (n) Mean (SD);% (n)
EGA at study entry (weeks) 18.7 (0.7) 18.7 (0.8)
Prior preterm birth 15.5% (n=9) 24.7% (n=18)
Typical daily cigarettes (#) 11.1 (6.2) 12.8 (6.6)
Positive UDS 2 weeks prior to delivery
 Benzodiazepines 5.6% (n=3) 1.4% (n=1)
 Cocaine 9.3% (n=5) 5.6% (n=4)
 Opiates 11.1% (n=6) 5.6% (n=4)
SSRIs 27.8% (n=16) 21.9% (n=16)
Anxiolytics 40.4% (n=23) 27.8 % (n=20)

Note. EGA: estimated gestational age; UDS: urine drug screen; SSRIs: maternal receipt of selective serotonin reuptake inhibitors, antidepressants, or antipsychotics